Ceritinib is a tyrosine kinase inhibitor that selectively and potently inhibits anaplastic lymphoma kinase (ALK). In regular physiology, ALK functions like a key stage in the development and performance of anxious method tissue. Nonetheless, chromosomal translocation and fusion give rise to an oncogenic type of ALK that's been implicated in https://ceritinib35780.wssblogs.com/31359831/details-fiction-and-ceritinib